Provides the official 2020 European Society of Cardiology clinical practice recommendations for diagnosing, risk-stratifying, and managing patients with non-ST-segment elevation acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Adoption standardizes NSTE-ACS care across Europe; extends prior guidelines with synthesized trial evidence on troponin and revascularization.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Collet et al. (2020) studied Acute coronary syndromes without persistent ST-segment elevation (NSTE-ACS). Guideline-directed diagnostic, pharmacological, and invasive management strategies for NSTE-ACS was evaluated. The 2020 ESC Guidelines provide updated recommendations for diagnosis, risk stratification, antithrombotic therapy, and invasive revascularization in patients with NSTE-ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: